ERBB2 and breast carcinoma: The majority of immunohistochemical staining investigations [1–3] have revealed similarities between SDC and breast carcinoma with positive immunostaining for epithelial markers such as cytokeratin and epithelial membrane antigen and particularly intense immunoreactivity for gross cystic disease fluid protein-15 (GCDFP-15), androgen receptor, and HER2/neu.